Table of Contents: Volume 10, Issue 1 - February 2002
Adjuvant Anastrozole Better than Tamoxifen: Early Results
01.MICHAEL BAUM, University College, London
[05:08 min:sec]
Metastatic Renal-Cell Cancer: Nephrectomy Still Helps
02.GEORGE CANELLOS, Dana-Farber Cancer Institute
[03:05 min:sec]
Radio-Labelled Antibody Helps Non Hodgkin's Lymphoma
03.ANDREW ZELENETZ, Memorial Sloan-Kettering Cancer Center, New York
[04:42 min:sec]
Rituximab: Latest Lymphoma Results
04.GEORGE CANELLOS, Dana-Farber Cancer Institute
[03:46 min:sec]
Translocation Shows Which Gastric MALT Tumours are Antibiotic-Curable
05.PETER ISAACSON, University College, London
[02:49 min:sec]
STI 571: Latest Clinical Data In CML
06.CHARLES SAWYERS, UCLA, Los Angeles
[03:40 min:sec]
Allogeneic Transplantation for CML in the STI Era
07.JOHN GOLDMAN, Hammersmith Hospital, London
[04:49 min:sec]
Gentler Regimen Brings Hodgkin's Disease Promise
08.SANDRA HORNING, Stanford University, California
[04:14 min:sec]
Pre-Operative Docetaxel Boosts Breast Cancer Remission Rates
09.HARRY BEAR, Virginia Commonwealth University, Richmond
[03:45 min:sec]
Avoiding Leukemia Caused by Breast Adjuvant Treatment
10.ROY SMITH, NSABP, Pittsburgh
[03:50 min:sec]
Pre-Operative Letrozole More Effective than Tamoxifen
11.MATTHEW ELLIS, Duke University, Durham
[04:51 min:sec]
Tamoxifen Prevents Benign Breast Lesions
12.ELIZABETH TAN-CHIU, NSABP, Pittsburgh
[02:24 min:sec]
Less Toxicity, Same Survival in Aggressive Lymphoma
13.GEORGE CANELLOS, Dana-Farber Cancer Institute
[03:57 min:sec]
Double Cure Rates in High Risk Local Bladder Cancer
14.RANDALL MILLIKAN, MD Anderson Cancer Center, Houston
[04:31 min:sec]
Listen to this audio by subscribing to the Podcast |
|---|